SEARCH

SEARCH BY CITATION

References

  • 1
    Drysdale R, Bayraktaroglu L. Current awareness. Yeast 2000; 17: 159166.
  • 2
    Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 11811189.
  • 3
    Thompson JA, Markey SP. Quantitative metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry: comparison of isolation methods. Anal Chem 1975; 47: 13131321.
  • 4
    Dunn WB, Bailey NJ, Johnson HE. Measuring the metabolome: current analytical technologies. Analyst 2005; 130: 606625.
  • 5
    Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004; 9: 131.
  • 6
    Smith IC, Baert R. Medical diagnosis by high resolution NMR of human specimens. IUBMB Life. 2003; 55: 273277.
  • 7
    Wishart DS, Querengesser LMM, Lefebvre BA, Epstein NA, Greiner R, Newton JB. Magnetic Resonance Diagnostics: A new technology for high-throughput clinical diagnostics. Clin Chem 2001; 47: 19181921.
  • 8
    Salaman JR. Monitoring of rejection in renal transplantation. Immunol Lett 1991; 29: 139142.
  • 9
    Bell JD, Lee JA, Lee HA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991; 1096: 101107.
  • 10
    Sinclair MC, Lemmi CA, Moore TC. Elevation in urinary excretion of histamine following renal allografting in rats. J Surg Res 1974; 17: 4344.
  • 11
    Saude EJ, Lacy P, Musat-Marcu S et al. NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. Magn Reson Med 2004; 52: 807814.
  • 12
    Zhao Y, Katz NM, Lefrak EA, Foegh ML. Urinary thromboxane B2 in cardiac transplant patients as a screening method of rejection. Prostaglandins 1997; 54: 881889.
  • 13
    Foxall PJ, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993; 43: 234245.
  • 14
    Feng J, Li X, Pei F, Chen X, Li S, Nie Y. 1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. Anal Biochem 2002; 301: 17.
  • 15
    Hauet T, Baumert H, Gibelin H et al. Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology 2000; 41: 280291.
  • 16
    Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005; 67: 11421151.
  • 17
    Le Moyec L, Pruna A, Eugene M et al. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993; 65: 433439.
  • 18
    Al Banchaabouchi M, Marescau B, D'Hooge R, Engelborghs S, De Deyn PP. Consequences of renal mass reduction on amino acid and biogenic amine levels in nephrectomized mice. Amino Acids 2000; 18: 265277.
  • 19
    Al Banchaabouchi M, Marescau B, D'Hooge R et al. Biochemical and histopathological changes in nephrectomized mice. Metabolism 1998; 47: 355361.
  • 20
    Dedeoglu IO, Feld LG. Decreased urinary excretion of nitric oxide in acute rejection episodes in pediatric renal allograft recipients. Transplantation 1996; 62: 19361968.
  • 21
    Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P. Subclinical rejection–a potential surrogate marker for chronic rejection–may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000; 5: 4449.
  • 22
    Silva MA, Richards DA, Bramhall SR, Adams DH, Mirza DF, Murphy N. A study of the metabolites of ischemia-reperfusion injury and selected amino acids in the liver using microdialysis during transplantation. Transplantation 2005; 79: 828835.
  • 23
    Gibelin H, Eugene M, Hebrard W, Henry C, Carretier M, Hauet T. A new approach to the evaluation of liver graft function by nuclear magnetic resonance spectroscopy. A comparative study between Euro-Collins and University of Wisconsin solutions. Clin Chem Lab Med 2000; 38: 11331136.
  • 24
    Martin-Sanz P, Olmedilla L, Dulin E et al. Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for liver function. Liver Transpl 2003; 9: 4048.
  • 25
    Singh HK, Yachha SK, Saxena R et al. A new dimension of 1H-NMR spectroscopy in assessment of liver graft dysfunction. NMR Biomed 2003; 16: 185188.
  • 26
    Melendez HV, Ahmadi D, Parkes HG, Rela M, Murphy G, Heaton N. Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation. Transplantation 2001; 72: 855860.
  • 27
    Mugge A, Kurucay S, Boger RH et al. Urinary nitrate excretion is increased in cardiac transplanted patients with acute graft rejection. Clin Transplant 1996; 10: 298305.
  • 28
    Eugene M, Le Moyec L, De Certaines J et al. Lipoproteins in heart transplantation: proton magnetic resonance spectroscopy of plasma. Magn Reson Med 1991; 18: 93101.
  • 29
    Mouly-Bandini A, Vion-Dury J, Viout P, Sciaky M, Mesana T, Cozzone PJ. Detection of acute cardiac rejection by high resolution proton magnetic resonance spectroscopy of plasma. MAGMA 2000; 11: 2732.
  • 30
    Lukes DJ, Madhu B, Kjellstrom C et al. Decreasing ratios of phosphocreatine to beta-ATP correlates to progressive acute rejection in a concordant mouse heart to rat xenotransplantation model. Scand J Immunol 2001; 53: 171175.
  • 31
    Kober F, Caus T, Riberi A et al. Objective and noninvasive metabolic characterization of donor hearts by phosphorous-31 magnetic resonance spectroscopy. Transplantation 2002; 74: 17521756.
  • 32
    Kugel H, Wittsack H-J, Wenzel F, Stippel D, Heindel W, Lackner K. Non-invasive determination of metabolite concentrations in human transplanted kidney in vivo by 31P MR spectroscopy. Acta Radiol 2000; 41: 634641.
  • 33
    Shapiro JI, Haug CE, Shanley PF, Weil R 3rd, Chan L. 31P nuclear magnetic resonance study of renal allograft rejection in the rat. Transplantation 1988; 45: 1721.
  • 34
    Lee CW, Lee JH, Kim JJ et al. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 1999; 33: 11961202.